Introduction
Chronic obstructive pulmonary disease (COPD) can make daily activities more difficult by causing ongoing breathing problems, chronic cough, fatigue, and reduced lung function. Many patients living with COPD require long-term maintenance medications to help control symptoms, improve airflow, and reduce the risk of flare-ups that may lead to hospitalization or worsening respiratory health.
Breztri Aerosphere is a triple-combination inhaler developed for maintenance treatment of COPD, including chronic bronchitis and emphysema. The inhaler combines three medications that work together to reduce airway inflammation, relax airway muscles, and improve breathing over time.
The medication contains budesonide, an inhaled corticosteroid that helps reduce airway inflammation, glycopyrrolate, a long-acting muscarinic antagonist that helps open the airways, and formoterol fumarate, a long-acting bronchodilator that improves airflow by relaxing airway muscles.
By combining these therapies into one inhaler, Breztri Aerosphere may help improve lung function, reduce COPD symptoms, and decrease the frequency of COPD flare-ups in eligible patients.
Breztri Aerosphere is intended for ongoing maintenance treatment and is not designed for sudden breathing emergencies. Patients are generally advised to continue carrying a rescue inhaler for immediate symptom relief when needed.
Although combination COPD inhalers may provide important respiratory benefits, specialty inhalers can also create affordability concerns. Patients may face high out-of-pocket expenses, insurance coverage challenges, pharmacy pricing differences, and ongoing refill costs throughout treatment.
Those who need a combination COPD inhaler but struggle financially may benefit from the Breztri Aerosphere Patient Assistance Program through Prescription Hope.
Understanding how Breztri Aerosphere works, possible treatment benefits, side effects, and available medication access resources can help patients feel more informed when discussing COPD treatment options with their healthcare provider.
What Is the Breztri Aerosphere Patient Assistance Program?
The Breztri Aerosphere Patient Assistance Program provides qualified patients with access to affordable Breztri Aerosphere.
Sometimes, when a brand-name medication comes to market, its retail cost is too high for most Americans to afford out of pocket. The pharmaceutical manufacturers understand this and have developed Patient Assistance Programs to help qualified patients access affordable medications such as Breztri Aerosphere.
Unfortunately, some of these programs are notoriously difficult to apply for.
Prescription Hope has developed a solution for patients who feel frustrated with the patient assistance program application process.
How Expert Advocates Help Make Breztri Aerosphere More Affordable
Professional Application Management
Prescription Hope provides support and advocacy throughout the patient assistance program application process. Plus, approved patients also receive administrative services to manage tasks such as refill scheduling, document updates, yearly renewals, and more.
Breztri Aerosphere Price Comparison
vs
Estimated Retail Price*
30-Day Supply
Prescription Hope Price
Per Month, NO Matter The Retail Price
*Source: Drugs.com
Predictable Monthly Pricing
Prescription Hope maintains a simple, predictable monthly service fee of $70.00 per month, per medication.
If patients do not qualify for their intended program, then we’ll work to help find alternative savings options. Some of these include other opportunities such as substitute medications and their programs, discount cards, coupons, and more.
And if we can’t help a patient save on their monthly medication costs, then they pay nothing.
Ongoing Advocacy and Refill Support
Those who qualify for inhaler affordability support through Prescription Hope also receive continuing administrative services, including refill scheduling, yearly renewals, program monitoring, and more.
Breztri Aerosphere Patient Assistance Eligibility
Breztri Aerosphere eligibility relies on meeting certain patient assistance qualifications. However, each program is different.
Every patient assistance program maintains specific eligibility requirements, and they typically fall into several categories. Those include:
Prescription status: Every program requires qualified patients to maintain a valid prescription for the medication they wish to apply for.
U.S. residency: All programs require qualified applicants to have legal U.S. resident status.
Income: Each program maintains a different income threshold.
Insurance: Each program sets its own insurance coverage status.
Simple Enrollment With Expert Support
Starting Your Journey
Those looking to enroll in the Breztri Aerosphere assistance program for COPD medication support need look no further than Prescription Hope.
Our team of patient advocates will gladly walk with you through our simple 6-step process:
- Submit Information: Take a few minutes to fill out our enrollment form. And feel free to give us a call if you have any questions.
- Advocate Contact: Once your form is completed, submit it to us, and a patient advocate will contact you within 1-2 business days.
- Document Collection: Once we’ve prequalified you, we’ll collect all the documentation required for your application.
- Provider Coordination: Our team will also gather needed signatures from your healthcare provider.
- Program Submission: After everything is in place, we’ll submit your application and follow up with the manufacturer.
- Medication Delivery: Once a patient is approved for a program, the manufacturer will ship the medication directly to their door or doctor’s office. Typically, patients can expect to receive their medication within 2 weeks after approval.
All medication shipments are handled by the manufacturers and not Prescription Hope.
Medication Delivery and Ongoing Support
Once you receive your shipment, we’ll continue to handle your refill scheduling, document updates, program monitoring, yearly renewals, and more.
Understanding Breztri Aerosphere
How Breztri Aerosphere Works
Breztri Aerosphere combines three medications that work together to improve breathing and support long-term COPD symptom control.
The inhaler contains:
- Budesonide — an inhaled corticosteroid (ICS) that helps reduce airway inflammation and swelling
- Glycopyrrolate — a long-acting muscarinic antagonist (LAMA) that helps relax airway muscles by blocking certain nerve signals
- Formoterol fumarate — a long-acting beta2-adrenergic agonist (LABA) that helps relax airway muscles and improve airflow
Together, these medications help:
- Improve airflow and lung function
- Reduce COPD-related breathing symptoms
- Decrease COPD flare-ups (exacerbations)
- Support long-term respiratory symptom control
Breztri Aerosphere is administered through oral inhalation using a pressurized metered-dose inhaler and is typically used twice daily.
The medication is intended for maintenance treatment and not for immediate relief of sudden breathing problems.
What Conditions Does Breztri Aerosphere Treat?
Breztri Aerosphere is FDA-approved for:
- Maintenance treatment of chronic obstructive pulmonary disease (COPD), including:
- Chronic bronchitis
- Emphysema
COPD is a chronic lung disease that can cause:
- Shortness of breath
- Wheezing
- Chronic cough
- Excess mucus production
- Reduced exercise tolerance
The medication is intended to help improve airflow, reduce respiratory symptoms, and decrease COPD flare-ups in eligible patients.
Breztri Aerosphere is not approved for asthma treatment and should not be used as a rescue inhaler for sudden breathing emergencies.
Healthcare providers evaluate lung function, symptom severity, exacerbation history, and overall respiratory health when determining whether Breztri Aerosphere may be an appropriate treatment option.
Benefits of Treatment
For many patients with COPD, Breztri Aerosphere may provide important long-term respiratory management benefits.
Potential benefits of Breztri Aerosphere treatment may include:
- Improved airflow and lung function
- Reduced COPD flare-ups
- Better day-to-day breathing control
- Reduced shortness of breath
- Combination therapy convenience in one inhaler
- Improvement in respiratory symptoms and daily COPD symptom control in some patients
Clinical studies demonstrated reductions in COPD exacerbations and improvements in respiratory symptoms in many patients receiving treatment.
Because Breztri Aerosphere combines three maintenance therapies into one inhaler, some patients may benefit from simplified treatment routines and broader symptom control.
Treatment effectiveness depends on proper inhaler technique, regular daily use, and ongoing follow-up care with a healthcare provider.
Important Safety Information and Side Effects
Like all respiratory medications, Breztri Aerosphere may cause side effects and carries important safety considerations. Patients should discuss the risks and benefits of treatment with their healthcare provider before starting therapy.
Breztri Aerosphere is not intended for sudden breathing emergencies or acute bronchospasm. Patients should continue to keep a rescue inhaler available for immediate symptom relief.
Common side effects associated with Breztri Aerosphere may include:
- Upper respiratory infections
- Pneumonia
- Oral thrush (fungal infection in the mouth)
- Cough
- Back pain
- Muscle spasms
- Diarrhea
- Urinary tract infection
- Hoarseness
Patients are generally advised to rinse their mouth after use to help reduce the risk of oral thrush.
Additional important safety considerations may include:
- Increased risk of pneumonia in COPD patients
- Increased susceptibility to infections
- Adrenal suppression or systemic corticosteroid effects with long-term use
- Reduced bone mineral density
- Increased intraocular pressure, glaucoma, or cataracts
- Urinary retention related to glycopyrrolate
- Cardiovascular effects such as increased heart rate or blood pressure
- Paradoxical bronchospasm, which may be life-threatening
- Serious allergic reactions
Patients should seek medical attention if they experience:
- Worsening breathing problems
- Chest pain
- Eye pain or blurred vision
- Difficulty urinating
- Signs of infection
Drug interactions may occur with certain heart medications, antifungals, and other inhaled therapies.
Patients should discuss active infections, immune system conditions, and all medications with their healthcare provider before starting treatment.
Breztri Aerosphere does not currently carry an FDA boxed warning.
Access to Multiple Medications
When a patient needs specialty medication assistance or respiratory medication support, they often also need multiple medication assistance.
Prescription Hope can help those who qualify access multiple brand-name medications.
Whether one or many, Prescription Hope’s service rate remains $70.00 per month, per medication, offering patients the opportunity to save hundreds or thousands on their monthly medication costs.
Why Choose Prescription Hope for Breztri Aerosphere Assistance
Experienced Advocacy Support
For 20 years, Prescription Hope has provided experienced advocacy support to patients across America. Our team of Florida-based patient advocates offers compassion and expertise to those seeking medication access, and we’re eager to provide you with the same great service.
Ongoing Medication Management
Prescription Hope doesn’t stop once the application is accepted. We continue to provide refill scheduling, document updates, yearly renewals, and more.
Transparent Monthly Pricing
We offer all of our services for a simple, low monthly fee of $70.00 per month, per medication.
Nationwide Medication Access Support
Prescription Hope has continued to expand its network across America. This network includes manufacturers and healthcare providers ready to help you get your affordable Breztri Aerosphere assistance.
Those looking for COPD inhaler support should enroll with Prescription Hope today to see if they qualify!
